US Patent Issued to MEDIMMUNE on July 21 for "Anti-STEAP2 chimeric antigen receptors and uses thereof" (Delaware, Maryland Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,707, issued on July 21, was assigned to MEDIMMUNE LLC (Gaithersburg, Md.).

"Anti-STEAP2 chimeric antigen receptors and uses thereof" was invented by Emily Bosco (Wilmington, Del.), Dewald Van Dyk (Wilmington, Del.), Gordon Moody (Wilmington, Del.), Christine Fazenbaker (Gaithersburg, Md.) and Chien-Ying Chang (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides chimeric antigen receptors and antibodies that comprise antigen-binding domains that specifically bind human STEAP2, nucleotides that encode the same, cells comprising the same, and methods of using the same in the treatment of cancer (e.g., prostate cance...